Flagship @ JPM 2025

Marija Tadin-Strapps, Head of Discovery Network at Pfizer, joins Alec Reynolds, Chief Operating Officer of Pioneering Medicines, for a discussion about progress in the strategic partnership between Pfizer and Flagship Pioneering. With five pre-clinical research programs launched in 2024, the partnership is off to a great start with explorations designed to drive portfolio creation in areas including obesity, cancer, cardiovascular and renal diseases.

Lovisa Afzelius, Co-Founder and Founding CEO, Metaphore Biotechnologies, and Uli Stilz, Head of Novo Nordisk’s Bio Innovation Hub, join Paul Biondi, Flagship General Partner and President of Pioneering Medicines, for a discussion about the research collaboration between the three companies to advance therapeutic options for people living with obesity, a condition which presents a serious disease burden with opportunities for new and potentially highly efficacious and durable medicines.

Tony Wood, Chief Scientific Officer at GSK, joins Paul Biondi, Flagship Pioneering General Partner and President of Pioneering Medicines, for a discussion on the Innovation Supply Chain partnership between GSK and Flagship Pioneering and our shared goal of discovering and developing a portfolio of transformational medicines and vaccines, starting in respiratory and immunology.

André Andonian, Chair of Asia Pacific and Strategic Advisor, Flagship Pioneering and Irene Cheong, Assistant Chief Executive, Innovation & Enterprise Division, A*STAR, will delve into the strategic vision and collaborative spirit behind the partnership between A*STAR and Flagship Pioneering. Moderated by Justine Levin-Allerhand, Executive Partner, Origination and Corporate Development, Flagship Pioneering, the conversation will cover the motivations for forming this partnership and how Flagship and A*STAR’s complementary expertise will drive innovative research collaboration, advance entrepreneurship, and accelerate talent development in Singapore and the broader Asia Pacific region.

Flagship Pioneering Founder and CEO Noubar Afeyan sits down with Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals, for a conversation on leading multi-product platform companies, pioneering innovation to bring about novel medicines for patients across multiple disease areas, and the future of therapeutic development.

Angela Hwang, CEO, Metaphore Biotechnologies & CEO-Partner, Flagship Pioneering joins Joy Right, Vice President Talent Acquisition and Executive Search, Flagship Pioneering, for a conversation on Angela’s leadership journey as a biopharma executive from her time at Pfizer, including as Chief Commercial Officer and President of the Global Biopharmaceuticals Business, to taking the helm at Flagship-founded Metaphore Biotechnologies.

Please join us for a panel discussion led by Flagship General Partner Avak Kahvejian and featuring Flagship Origination Partners Kyle Chiang, Molly Gibson and Jake Rubens, about Flagship’s unique bioplatform approach to company creation and how we are leveraging breakthrough technologies to enable a range of therapeutic opportunities.

Stephen Hahn, CEO of Harbinger Health, Craig Williams, CEO of Apriori Bio, and Raj Panjabi, Senior Partner and Head of Flagship Pioneering's Preemptive Health and Medicine Initiative, join Christine Heenan, Flagship Chief Communications Officer and Executive Partner, for a discussion on novel preemptive health and medicine interventions that protect, maintain and improve people's health before they get sick.

Amanda Kay, Senior Partner and Chief Business Development Officer, will explore the broad range of early-stage deal constructs that create value for biotechs and pharma through a conversation with leaders on both sides of the table: John Delyani, Chief Business Officer, Repertoire Immune Medicines; Liz Leveille, VP, BD&L and Head of the Boston and European Innovation Hubs and Discovery Translation, Merck; Sahm Nasseri, SVP, Business Development and Strategy, Generate Biomedicines; and Gianfranco de Pascale, Director of Search & Evaluation, BD&L, Novartis.

Mickey Atwal, Chief Data and AI Officer at Pioneering Intelligence, Molly Gibson, Origination Partner at Flagship Pioneering, and Rajesh Ramaswamy, SVP, Head of Machine Learning and Artificial Intelligence Strategy at Sail Biomedicines, join Marcello Damiani, Flagship Senior Partner and Co-lead of Pioneering Intelligence, for a discussion on the AI innovations driving breakthroughs in drug discovery and design, and how AI is proving to be a core value driver to make leaps in human health.